Mednet Logo
HomeQuestion

What is a preferred regimen for metastatic leiomyosarcoma after failure of doxorubicin/olaratumab and gemcitabine/docetaxel?

1 Answers
Mednet Member
Mednet Member
Medical Oncology · The Royal Marsden

What is a preferred regimen for metastatic leiomyosarcoma after failure of doxorubicin/olaratumab and gemcitabine/docetaxel?

I would consider treatment with either trabectedin or pazopanib.

Register or Sign In to see full answer